From Dr Joe Campbell from Hattiesburg, MS on the Y

Quote:

---

As a physician who deals with pandemic issues daily I am here to tell you it's as bad as it's ever been. Today 5 of my operating room techs tested positive. Our ICU is now full. The Alpha article downplaying the severity and saying the standard of care is so much better now, well that's because early in the pandemic we were so bad at treating ventilated patients that 80 percent of them died. It's better now but the chances of mortality once on a ventilator is still very high and these patients are spending weeks in the ICUs and are getting tracheotomies sometimes three to four weeks after being in the unit. They are frequently having permanent lung, neurological or kidney damage if they survive. The cost of these hospitalizations is frequently over $100k per patient. We are doing all the state of the art stuff, IV Redesivir, dendron, high tech ventilators, dialysis...
Yeah SOC is better, but it is still is terrible. Don't fall for the short message that SOC has caught up with LL.
I don't know what will happen in the next day or so in regards to EUA, but I can tell you there won't be enough if it gets one. I read all Seaking Alpha article put out today about how Cytodyn is burning through cash, how they haven't applied for OWS, how NP has been inept in trying to get approval and how his CCs are often counterproductive to the SP. I also saw that they owe Samsung millions of dollars they don't have to manufacture and stockpile thousands of doses which are available for use NOW. If only we could get our hands on some in my ICUs here and get these patients off the ventilators. At a cost of $1200 a week if we shorten an ICU stay by only a couple of hours it pays for itself. From the data I have seen, I think it would cut ICU stays in half or better. The bill to Samsung will then be chump change.
I just need to get it, as does every other critical care doctor in the world. I hope the FDA sees this the way I do.
I know the shorts are trolling us and want to drive this company into the ground to make a few bucks, but believe me, the data shows it works and every critical care doctor in the world will want to use it immediately once the statistically significant proof of the CD12 trial is publicized, even if it's stopped early because of statistically significant positive outcomes. Damn the torpedoes.

---